PDCD1 and primary cutaneous T-cell non-Hodgkin lymphoma: Although the data on the expression pattern of PD-1 axis in CTCL are limited, they suggest a potential role of these negative immune regulators in the pathogenesis of CTCL and designate them as therapeutic targets.